HeraMED (ASX:HMD) onboarded more than 3,800 expectant mothers onto the HeraCARE maternity monitoring and management platform as of Sept. 30, according to a Tuesday filing with the Australian bourse.
The platform currently reached a new record of 710 expectant mothers, the filing stated.
The medical data and technology company attributed its growth to US-based Broward Health, which added 207 active users in its first 100 days of going live with HeraCARE.
HeraMED's shares were up nearly 5% in recent trade.
Price (AUD): $0.02, Change: $+0.00100, Percent Change: +4.76%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。